Baseline Assessment of Alcohol-Related Knowledge of and Support for Alcohol Warning Labels Among Alcohol Consumers in Northern Canada and Associations With Key Sociodemographic Characteristics.


Journal

Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847

Informations de publication

Date de publication:
03 2020
Historique:
entrez: 3 5 2020
pubmed: 3 5 2020
medline: 21 10 2020
Statut: ppublish

Résumé

Evidence-informed alcohol warning labels (AWLs) are a promising, well-targeted strategy to increase consumer awareness of health risks. We assessed consumers' baseline knowledge of alcohol-related cancer risk, standard drinks, and low-risk drinking guidelines as well as levels of support for AWLs. We further assessed associations with sociodemographic factors. Forming part of a larger study testing new evidence-informed AWLs in a northern Canadian territory compared with a neighboring territory, baseline surveys were completed among liquor store patrons systematically selected in both sites. Chi-square and multivariable logistic regression analyses were performed to assess outcomes. In total, 836 liquor store patrons (47.8% female) completed baseline surveys across both sites. Overall, there was low knowledge of alcohol-related cancer risk (24.5%), limited ability to calculate a standard drink (29.5%), and low knowledge of daily (49.5%) and weekly (48.2%) low-risk drinking guideline limits. There was moderate support for AWLs with a health warning (55.9%) and standard drink information (51.4%), and lower support for low-risk drinking guideline labels (38.7%). No sociodemographic characteristics were associated with cancer knowledge. Identifying as female and having adequate health literacy were associated with support for all three AWLs; high alcohol use was associated with not supporting standard drink (adjusted odds ratio = 0.60, 95% CI [0.40, 0.88]) and low-risk drinking guideline (adjusted odds ratio = 0.57, 95% CI [0.38, 0.87]) labels. Few consumers in this study had key alcohol-related health knowledge; however, there was moderate support for AWLs as a tool to raise awareness. Implementation of information-based interventions such as evidence-informed AWLs with health messages including alcohol-related cancer risk, standard drink information, and national drinking guidelines is warranted.

Identifiants

pubmed: 32359055
pmc: PMC7201212

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

238-248

Subventions

Organisme : NIAAA NIH HHS
ID : P50 AA005595
Pays : United States

Références

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):429-437
pubmed: 29615419
Drug Alcohol Rev. 2012 Mar;31(2):213-23
pubmed: 22176516
Aust N Z J Public Health. 2014 Feb;38(1):66-72
pubmed: 24494949
BMC Med. 2014 Oct 21;12:189
pubmed: 25424648
Addiction. 2016 Jul;111(7):1293-8
pubmed: 27073140
BMC Public Health. 2018 Jun 4;18(1):688
pubmed: 29866082
Tob Control. 2011 Sep;20(5):327-37
pubmed: 21606180
Health Educ Res. 2016 Feb;31(1):60-9
pubmed: 26787351
Drug Alcohol Rev. 2009 May;28(3):263-74
pubmed: 21462409
Ann Fam Med. 2005 Nov-Dec;3(6):514-22
pubmed: 16338915
Milbank Q. 2017 Sep;95(3):494-534
pubmed: 28895220
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Drug Alcohol Rev. 2012 Mar;31(2):224-30
pubmed: 22220817
Addict Behav. 2005 Mar;30(3):403-13
pubmed: 15718058
Lancet. 2019 Jun 22;393(10190):2493-2502
pubmed: 31076174
Can J Public Health. 2018 Aug;109(4):506-515
pubmed: 29981100
Drug Alcohol Rev. 2016 Nov;35(6):661-664
pubmed: 27785844
Br J Cancer. 2009 Dec 3;101 Suppl 2:S18-23
pubmed: 19956158
Soc Sci Med. 2017 Mar;177:177-189
pubmed: 28171817
Int J Environ Res Public Health. 2020 Jan 07;17(2):
pubmed: 31936173
Int J Drug Policy. 2015 Apr;26(4):371-9
pubmed: 25217801
Drug Alcohol Rev. 2018 Mar;37(3):313-315
pubmed: 29446154
Cancer Epidemiol Biomarkers Prev. 2019 Jul;28(7):1195-1201
pubmed: 31043419
Soc Sci Med. 2014 Jul;113:104-9
pubmed: 24858928
Alcohol Alcohol. 2018 Jan 1;53(1):20-25
pubmed: 29016716
Drug Alcohol Rev. 2018 Mar;37(3):293-303
pubmed: 28881410
J Stud Alcohol Drugs. 2020 Mar;81(2):249-261
pubmed: 32359056
Addiction. 2017 Feb;112(2):222-228
pubmed: 27442501
Drug Alcohol Depend. 2018 Nov 1;192:163-170
pubmed: 30265999
J Public Health (Oxf). 2018 Sep 1;40(3):549-556
pubmed: 28977621
Health Promot Pract. 2019 Nov;20(6):905-913
pubmed: 29907073
BMC Public Health. 2014 Aug 03;14:786
pubmed: 25087010
Subst Use Misuse. 2018 Mar 21;53(4):585-595
pubmed: 28937874
Drug Alcohol Rev. 2011 Nov;30(6):652-8
pubmed: 21355915
JMIR Res Protoc. 2020 Jan 10;9(1):e16320
pubmed: 31922493
BMC Public Health. 2016 Nov 30;16(1):1194
pubmed: 27899099
BMC Public Health. 2016 Feb 11;16:139
pubmed: 26864239
J Stud Alcohol Drugs. 2020 Mar;81(2):225-237
pubmed: 32359054
Alcohol Clin Exp Res. 2016 Jun;40(6):1166-81
pubmed: 27130687
J Stud Alcohol Drugs. 2020 Mar;81(2):273-283
pubmed: 32359058
Alcohol Alcohol. 2018 Jan 1;53(1):3-11
pubmed: 29016708
Drug Alcohol Rev. 2012 Mar;31(2):206-12
pubmed: 22050096
J Stud Alcohol Drugs. 2020 Mar;81(2):262-272
pubmed: 32359057
Addiction. 2018 Dec;113(12):2225-2232
pubmed: 30136436
Drug Alcohol Rev. 2012 Mar;31(2):240-7
pubmed: 21824209
Can J Public Health. 2015 Apr 29;106(4):e204-9
pubmed: 26285191

Auteurs

Kate Vallance (K)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Tim Stockwell (T)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Jinhui Zhao (J)

Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada.

Simran Shokar (S)

Canadian Agency for Drugs and Technologies in Health, Toronto, Ontario, Canada.

Nour Schoueri-Mychasiw (N)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, Ontario, Canada.

David Hammond (D)

School of Public Health & Health Systems, University of Waterloo, Waterloo, Ontario, Canada.

Thomas K Greenfield (TK)

Alcohol Research Group, Public Health Institute, Emeryville, California, United States.

Jonathan McGavock (J)

Department of Pediatrics and Child Health, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

Ashini Weerasinghe (A)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, Ontario, Canada.

Erin Hobin (E)

Health Promotion, Chronic Disease and Injury Prevention, Public Health Ontario, Toronto, Ontario, Canada.
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH